These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ADAM8: a new therapeutic target for asthma. Knolle MD; Owen CA Expert Opin Ther Targets; 2009 May; 13(5):523-40. PubMed ID: 19397475 [TBL] [Abstract][Full Text] [Related]
3. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Van Eerdewegh P; Little RD; Dupuis J; Del Mastro RG; Falls K; Simon J; Torrey D; Pandit S; McKenny J; Braunschweiger K; Walsh A; Liu Z; Hayward B; Folz C; Manning SP; Bawa A; Saracino L; Thackston M; Benchekroun Y; Capparell N; Wang M; Adair R; Feng Y; Dubois J; FitzGerald MG; Huang H; Gibson R; Allen KM; Pedan A; Danzig MR; Umland SP; Egan RW; Cuss FM; Rorke S; Clough JB; Holloway JW; Holgate ST; Keith TP Nature; 2002 Jul; 418(6896):426-30. PubMed ID: 12110844 [TBL] [Abstract][Full Text] [Related]
4. Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma. Ghosh A; Koziol-White CJ; Asosingh K; Cheng G; Ruple L; Groneberg D; Friebe A; Comhair SA; Stasch JP; Panettieri RA; Aronica MA; Erzurum SC; Stuehr DJ Proc Natl Acad Sci U S A; 2016 Apr; 113(17):E2355-62. PubMed ID: 27071111 [TBL] [Abstract][Full Text] [Related]
5. ADAM metallopeptidase domain 33 (ADAM33): identification and role in airways disease. Holgate ST Drug News Perspect; 2010; 23(6):381-7. PubMed ID: 20697605 [TBL] [Abstract][Full Text] [Related]
6. Smoke exposure interacts with ADAM33 polymorphisms in the development of lung function and hyperresponsiveness. Reijmerink NE; Kerkhof M; Koppelman GH; Gerritsen J; de Jongste JC; Smit HA; Brunekreef B; Postma DS Allergy; 2009 Jun; 64(6):898-904. PubMed ID: 19236319 [TBL] [Abstract][Full Text] [Related]
7. ADAM33's Role in Asthma Pathogenesis: An Overview. Sleziak J; Gawor A; Błażejewska M; Antosz K; Gomułka K Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396994 [TBL] [Abstract][Full Text] [Related]
8. [Progress in study of ADAM33 gene]. Su ZG; Wen FQ; Feng YL Yi Chuan; 2005 Jul; 27(4):636-40. PubMed ID: 16120592 [TBL] [Abstract][Full Text] [Related]
9. Bronchial hyperresponsiveness in adolescents with long-term asthma remission: importance of a Family history of bronchial hyperresponsiveness. Koh YY; Kang EK; Kang H; Yoo Y; Park Y; Kim CK Chest; 2003 Sep; 124(3):819-25. PubMed ID: 12970003 [TBL] [Abstract][Full Text] [Related]
10. Molecular interaction network and pathway studies of ADAM33 potentially relevant to asthma. Vishweswaraiah S; Veerappa AM; Mahesh PA; Jayaraju BS; Krishnarao CS; Ramachandra NB Ann Allergy Asthma Immunol; 2014 Oct; 113(4):418-24.e1. PubMed ID: 25155083 [TBL] [Abstract][Full Text] [Related]
11. Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. Holgate ST; Holloway J; Wilson S; Howarth PH; Haitchi HM; Babu S; Davies DE J Allergy Clin Immunol; 2006 Mar; 117(3):496-506; quiz 507. PubMed ID: 16522446 [TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids ameliorate antigen-induced bronchial smooth muscle hyperresponsiveness by inhibiting upregulation of RhoA in rats. Chiba Y; Goto K; Hirahara M; Sakai H; Misawa M J Pharmacol Sci; 2008 Apr; 106(4):615-25. PubMed ID: 18391481 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel polymorphisms in the Adam33 gene. Chae SC; Yoon KH; Chung HT J Hum Genet; 2003; 48(5):278-281. PubMed ID: 12768445 [TBL] [Abstract][Full Text] [Related]
16. The role of ADAM33 in the pathogenesis of asthma. Cakebread JA; Haitchi HM; Holloway JW; Powell RM; Keith T; Davies DE; Holgate ST Springer Semin Immunopathol; 2004 Feb; 25(3-4):361-75. PubMed ID: 14999429 [TBL] [Abstract][Full Text] [Related]
18. Asthma therapy: how far have we come, why did we fail and where should we go next? Janssen LJ Eur Respir J; 2009 Jan; 33(1):11-20. PubMed ID: 19118224 [TBL] [Abstract][Full Text] [Related]